Thought leadership articles

For our 5th anniversary, we took the opportunity to interview a few leading voices in the field of science and […]

As we continue to celebrate Dewpoint’s 5-year anniversary, some of our most tenured employees shared their memories of the beginning […]

Akin to shoppers, farmers and artisans congregating at the town park every Saturday for Farmer’s market, biomolecular condensation is a […]

Over the last 5 years, our team at Dewpoint has made astounding progress. We have taken the theoretical ideas of […]

Dewpoint Therapeutics was founded five years ago, and today we are poised to ignite the science of biomolecular condensates into […]

Isaac Klein, M.D., Ph.D. How did the discovery of condensates transform our understanding of the cell? We thought the cell […]

Boston, Massachusetts, March 26, 2025 – Dewpoint Therapeutics Inc. – the leading biotechnology company in transforming condensate biology into medicine, […]

Boston, Massachusetts, January 29, 2025 – Dewpoint Therapeutics Inc. – the leading biotechnology company in transforming condensate biology into medicine, […]

Supporting Dewpoint’s novel condensate modulating approach to drug previously ‘undruggable’ therapeutic targets, guided by ConcertAI’s Clinico-Genomic Solutions  Boston, MA and […]

BOSTON, Massachusetts, December 4, 2024 – Dewpoint Therapeutics Inc., the leading biotechnology company that develops therapeutics by targeting biomolecular condensates, announced today […]